Form D · Pharmaceuticals

EVESTRA INC

San Antonio, TX · CIK 0001440876

Offering snapshot reported Dec 15, 2009 · SEC filing

Reported sold
$1.8M
Offering amount: $4M
Investors reported
14
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Oct 19, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$900K$1.8MDec 14, 2009: $1,800,000.00Dec 14, 2009Dec 15, 2009: $1,800,000.00Dec 15, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 15, 2009AmendmentYet to sellNo comparison14SEC filing
Dec 15, 2009Amendment$1,800,000$0vs Dec 14, 200914SEC filing
Dec 14, 2009Initial$1,800,000No comparison14SEC filing
Jul 21, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-120647

Source: Form D, filed Dec 15, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John R. Hurd Director
Hurd R. John Director
John C. Kerr Director
Klaus Nickisch Director, Executive
Ze'ev Shaked Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
7620 Nw Loop 410
San Antonio, TX, 78227